TY - JOUR
T1 - Distinguishing true from false positives in genomic studies
T2 - P values
AU - Broer, Linda
AU - Lill, Christina M.
AU - Schuur, Maaike
AU - Amin, Najaf
AU - Roehr, Johannes T.
AU - Bertram, Lars
AU - Ioannidis, John P.A.
AU - Van Duijn, Cornelia M.
N1 - Funding Information:
Acknowledgments The study was supported by grants from the Centre for Medical Systems Biology (CMSB) and ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. The genetics databases used for this project have been made possible by the kind support of the Cure Alzheimer’s Fund (CAF), the Michael J. Fox Foundation (MJFF) for Parkinson’s Research, the National Alliance for Research on Schizophrenia and Depression (NARSAD), Prize4-Life, and EMD Serono. C.M.L. is supported by the Fidelity Biosciences Research Initiative. L.Bertram is supported by the German Ministry for Education and Research (BMBF).
PY - 2013/2
Y1 - 2013/2
N2 - Distinguishing true from false positive findings is a major challenge in human genetic epidemiology. Several strategies have been devised to facilitate this, including the positive predictive value (PPV) and a set of epidemiological criteria, known as the "Venice" criteria. The PPV measures the probability of a true association, given a statistically significant finding, while the Venice criteria grade the credibility based on the amount of evidence, consistency of replication and protection from bias. A vast majority of journals use significance thresholds to identify the true positive findings. We studied the effect of p value thresholds on the PPV and used the PPV and Venice criteria to define usable thresholds of statistical significance. Theoretical and empirical analyses of data published on AlzGene show that at a nominal p value threshold of 0.05 most "positive" findings will turn out to be false if the prior probability of association is below 0.10 even if the statistical power of the study is higher than 0.80. However, in underpowered studies (0.25) with a low prior probability of 1 × 10-3, a p value of 1 × 10-5 yields a high PPV (>96 %). Here we have shown that the p value threshold of 1 × 10-5 gives a very strong evidence of association in almost all studies. However, in the case of a very high prior probability of association (0.50) a p value threshold of 0.05 may be sufficient, while for studies with very low prior probability of association (1 × 10-4; genome-wide association studies for instance) 1 × 10-7 may serve as a useful threshold to declare significance.
AB - Distinguishing true from false positive findings is a major challenge in human genetic epidemiology. Several strategies have been devised to facilitate this, including the positive predictive value (PPV) and a set of epidemiological criteria, known as the "Venice" criteria. The PPV measures the probability of a true association, given a statistically significant finding, while the Venice criteria grade the credibility based on the amount of evidence, consistency of replication and protection from bias. A vast majority of journals use significance thresholds to identify the true positive findings. We studied the effect of p value thresholds on the PPV and used the PPV and Venice criteria to define usable thresholds of statistical significance. Theoretical and empirical analyses of data published on AlzGene show that at a nominal p value threshold of 0.05 most "positive" findings will turn out to be false if the prior probability of association is below 0.10 even if the statistical power of the study is higher than 0.80. However, in underpowered studies (0.25) with a low prior probability of 1 × 10-3, a p value of 1 × 10-5 yields a high PPV (>96 %). Here we have shown that the p value threshold of 1 × 10-5 gives a very strong evidence of association in almost all studies. However, in the case of a very high prior probability of association (0.50) a p value threshold of 0.05 may be sufficient, while for studies with very low prior probability of association (1 × 10-4; genome-wide association studies for instance) 1 × 10-7 may serve as a useful threshold to declare significance.
KW - "-Omics"
KW - Alzheimer's disease
KW - Significance thresholds
KW - Venice Criteria
UR - http://www.scopus.com/inward/record.url?scp=84879506977&partnerID=8YFLogxK
U2 - 10.1007/s10654-012-9755-x
DO - 10.1007/s10654-012-9755-x
M3 - Article
C2 - 23371043
AN - SCOPUS:84879506977
SN - 0393-2990
VL - 28
SP - 131
EP - 138
JO - European Journal of Epidemiology
JF - European Journal of Epidemiology
IS - 2
ER -